Commonly Reported Effects The most frequently mentioned side effect is next-morning fatigue or grogginess, typically reported when doses exceed individual tolerance or timing is off
The KLOW 80mg vial contains KPV 10mg (Lys-Pro-Val, the C-terminal tripeptide of alpha-melanocyte-stimulating hormone at residues 11 to 13, 342.4 g/mol, CAS 64790-08-5), BPC-157 10mg (pentadecapeptide GEPPPGKPADDAGLV, 1419.53 g/mol, CAS 137525-51-0), TB-500 10mg (synthetic thymosin beta 4, 43 residues, 4963.4 g/mol, CAS 77591-33-4) and GHK-Cu 50mg (glycyl-L-histidyl-L-lysine copper(II) complex, 403.9 g/mol, CAS 89030-95-5), co-lyophilised in one container
BPC-157 is a synthetic 15-amino acid peptide derived from human gastric juice that demonstrates significant wound healing properties in preclinical research
Targets NAD+ restoration, mitochondrial function, and cellular bioenergetics for comprehensive aging studies
These products have not been evaluated or approved by the U.S